Showing 1-8 of 8 results for "f4516"
Evidence for antibody-mediated pathogenesis in anti-NMDAR
encephalitis associated with ovarian teratoma
Erdem Tuzun, et al.
Acta Neuropathologica, 118(6) (2009)
Elion Hoxha et al.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26(8), 2526-2532 (2011-06-03)
The recent finding that phospholipase-A(2)-receptor antibodies (PLA(2)R-AB) may play a role in the development of primary membranous glomerulonephritis (MGN) offers the opportunity to measure a marker to help diagnose, classify and eventually monitor the course of patients with MGN. We...
Zijun Yang et al.
Oncology letters, 21(3), 176-176 (2021-02-13)
Cell migration is an important factor influencing the treatment outcomes of high-grade glioma (World Health Organization grades III-IV). Using immunohistochemical staining, the present study demonstrated that the protein levels of phosphorylated pyruvate dehydrogenase α1 (p-PDHA1) were increased according to the...
Aki Kuroki et al.
Kidney international, 68(1), 302-310 (2005-06-16)
The predominant deposition of IgG4 in idiopathic membranous nephropathy indicates that its presence characterizes the systemic immune response of the disease. We analyzed the expressions of CD3, CD19, CD4, and CD8 on peripheral blood mononuclear cells (PBMCs) by flow cytometry...
Human placental Fc receptors and the transmission of antibodies from mother to fetus.
Simister NE and Story CM
Journal of Reproductive Immunology, 37(1) (1997)
Antibody structure, instability, and formulation.
Wang W, et al.
Journal of Pharmaceutical Sciences (2007)
Immunobiology (2001)
Elion Hoxha et al.
Kidney international, 82(7), 797-804 (2012-06-08)
The M-type phospholipase A2 receptor (PLA2R) is the major target antigen in idiopathic membranous nephropathy with detectable autoantibodies in the serum of up to 70% of patients. In retrospective studies, the PLA2R-autoantibody titer in the serum was sometimes negative indicating...

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon


Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.